Impact of Retinal Ischemia on Visual Acuity Outcomes

Related

• 

  Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial

  Philip J. Ferrone, MD, FASRS

  Annual Meeting Talks

  2019

• 

  Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting

  Marko Lukic, MD PhD FEBO FASRS

  On Demand Cases, Courses, and Papers

  2019

• 

  Journal Club with Dr. Ferhina Ali and Dr. Daniel Chao Discussing Caffeine and Beta Blockers for Vitreoretinal Surgeons, Cost-Savings with Intravitreal Bevacizumab, and more

  Jayanth Sridhar, MD

  Daniel L Chao, MD, PhD

  Ferhina S Ali, MD, MPH

  Member Podcasts

  2020